These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30186165)

  • 1. Association Between
    Chen H; Wu J; Zhang Z; Tang Y; Li X; Liu S; Cao S; Li X
    Front Pharmacol; 2018; 9():909. PubMed ID: 30186165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
    Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
    Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Profiling Comparison of Germline
    Huang X; Shao D; Wu H; Zhu C; Guo D; Zhou Y; Chen C; Lin Y; Lu T; Zhao B; Wang C; Sun Q
    Front Oncol; 2020; 10():583314. PubMed ID: 33194720
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between BRCA Status and P53 Status in Breast Cancer: A Meta-Analysis.
    Peng L; Xu T; Long T; Zuo H
    Med Sci Monit; 2016 Jun; 22():1939-45. PubMed ID: 27272763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
    Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
    Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
    Atchley DP; Albarracin CT; Lopez A; Valero V; Amos CI; Gonzalez-Angulo AM; Hortobagyi GN; Arun BK
    J Clin Oncol; 2008 Sep; 26(26):4282-8. PubMed ID: 18779615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between basal-like phenotype and
    Jung J; Kang E; Gwak JM; Seo AN; Park SY; Lee AS; Baek H; Chae S; Kim EK; Kim SW
    Curr Oncol; 2016 Oct; 23(5):298-303. PubMed ID: 27803593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.
    Wong-Brown MW; Meldrum CJ; Carpenter JE; Clarke CL; Narod SA; Jakubowska A; Rudnicka H; Lubinski J; Scott RJ
    Breast Cancer Res Treat; 2015 Feb; 150(1):71-80. PubMed ID: 25682074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
    Pellegrino B; Bella M; Michiara M; Zanelli P; Naldi N; Porzio R; Bortesi B; Boggiani D; Zanoni D; Camisa R; Neri TM; Pinto C; Musolino A
    Acta Biomed; 2016 May; 87(1):54-63. PubMed ID: 27163896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
    Bayraktar S; Gutierrez-Barrera AM; Liu D; Tasbas T; Akar U; Litton JK; Lin E; Albarracin CT; Meric-Bernstam F; Gonzalez-Angulo AM; Hortobagyi GN; Arun BK
    Breast Cancer Res Treat; 2011 Nov; 130(1):145-53. PubMed ID: 21830012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
    Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M
    Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative breast cancer frequency and type of
    Palomba G; Budroni M; Olmeo N; Atzori F; Ionta MT; Pisano M; Tanda F; Cossu A; Palmieri G
    Oncol Lett; 2014 Apr; 7(4):948-952. PubMed ID: 24944648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.
    Kwong A; Wong LP; Wong HN; Law FB; Ng EK; Tang YH; Chan WK; Suen DT; Choi C; Ho LS; Kwan KH; Poon M; Wong TT; Chan K; Chan SW; Ying MW; Chan WC; Ma ES; Ford JM; West DW
    Hugo J; 2009 Dec; 3(1-4):63-76. PubMed ID: 20535403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
    Oh M; McBride A; Yun S; Bhattacharjee S; Slack M; Martin JR; Jeter J; Abraham I
    J Natl Cancer Inst; 2018 Nov; 110(11):1178-1189. PubMed ID: 30380096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
    Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
    BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
    Zhu Y; Wu J; Zhang C; Sun S; Zhang J; Liu W; Huang J; Zhang Z
    Oncotarget; 2016 Oct; 7(43):70113-70127. PubMed ID: 27659521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis.
    Feng Z; Yang X; Tian M; Zeng N; Bai Z; Deng W; Zhao Y; Guo J; Yang Y; Zhang Z; Yang Y
    BMC Cancer; 2023 Aug; 23(1):807. PubMed ID: 37644384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
    Engel C; Rhiem K; Hahnen E; Loibl S; Weber KE; Seiler S; Zachariae S; Hauke J; Wappenschmidt B; Waha A; Blümcke B; Kiechle M; Meindl A; Niederacher D; Bartram CR; Speiser D; Schlegelberger B; Arnold N; Wieacker P; Leinert E; Gehrig A; Briest S; Kast K; Riess O; Emons G; Weber BHF; Engel J; Schmutzler RK;
    BMC Cancer; 2018 Mar; 18(1):265. PubMed ID: 29514593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.